CAT vs TRDA · P/E 48, rev $20.54B vs P/E 12, rev $210.8M
Caterpillar Inc (CAT) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CAT and TRDA stock pages for the full models.
Not investment advice.